From ASCO—urological cancer: Continuous dosing is preferred option for prostate cancer
11:40 EDT 19 Jun 2012 | Nature Publishing
Original Article: From ASCO—urological cancer: Continuous dosing is preferred option for prostate cancer
More From BioPortfolio on "From ASCO—urological cancer: Continuous dosing is preferred option for prostate cancer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
